SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • May 12th, 2020 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Separation and Consulting Agreement (the “Agreement”), dated as of May 6, 2020, is entered into between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”), and Mark C. Capone (“Capone” and, together with the Company, the “Parties” and each a “Party”).
